↓ Skip to main content

Dove Medical Press

Medication transitions and polypharmacy in older adults following acute care

Overview of attention for article published in Therapeutics and Clinical Risk Management, March 2014
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (70th percentile)
  • Good Attention Score compared to outputs of the same age and source (76th percentile)

Mentioned by

policy
1 policy source
googleplus
1 Google+ user

Citations

dimensions_citation
29 Dimensions

Readers on

mendeley
71 Mendeley
Title
Medication transitions and polypharmacy in older adults following acute care
Published in
Therapeutics and Clinical Risk Management, March 2014
DOI 10.2147/tcrm.s58707
Pubmed ID
Authors

John-Michael Gamble, Jill J Hall, Thomas J Marrie, Cheryl A Sadowski, Sumit R Majumdar, Dean T Eurich

Abstract

Medication changes at transitions of care and polypharmacy are growing concerns that adversely impact optimal drug use. We aimed to describe transitions and patterns of medication use before and 1 year after older patients were hospitalized for community-acquired pneumonia, the second-most common reason for admission in North America.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Ireland 1 1%
Switzerland 1 1%
Unknown 69 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 21%
Student > Ph. D. Student 7 10%
Student > Master 7 10%
Student > Bachelor 7 10%
Other 5 7%
Other 8 11%
Unknown 22 31%
Readers by discipline Count As %
Medicine and Dentistry 18 25%
Nursing and Health Professions 7 10%
Pharmacology, Toxicology and Pharmaceutical Science 6 8%
Psychology 2 3%
Social Sciences 2 3%
Other 9 13%
Unknown 27 38%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 30 August 2015.
All research outputs
#7,355,485
of 25,373,627 outputs
Outputs from Therapeutics and Clinical Risk Management
#379
of 1,323 outputs
Outputs of similar age
#66,101
of 236,365 outputs
Outputs of similar age from Therapeutics and Clinical Risk Management
#6
of 25 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 1,323 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 236,365 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 70% of its contemporaries.
We're also able to compare this research output to 25 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 76% of its contemporaries.